Objectives To compare the cross-sectional robustness of commonly used volumetric
software and effects of lesion filling in multiple sclerosis (MS). Methods Nine MS patients (six …

Brain volumetric measurements in multiple sclerosis (MS) reflect not only disease-specific
processes but also other sources of variability. The latter has to be considered especially in …

Background Whole brain volume (WBV) estimates in patients with multiple sclerosis (MS)
correlate more robustly with clinical disability than traditional, lesion-based metrics …

BACKGROUND AND PURPOSE: MR imaging can be used to measure structural changes in
the brains of individuals with multiple sclerosis and is essential for diagnosis, longitudinal …

BACKGROUND AND PURPOSE: Brain volume loss is currently a MR imaging marker of
neurodegeneration in MS. Available quantification algorithms perform either direct …

The aim of this study was to simultaneously measure in vivo volumes of gray matter (GM),
normal white matter (WM), abnormal white matter (aWM), and cerebro-spinal fluid (CSF) …

OBJECTIVES To assess whether multiple sclerosis lesion volume measurements derived
using the fast fluid attenuated inversion recovery (fFLAIR) sequence show better …

We used SPM99 to obtain normalized whole brain volumes of gray matter, white matter, and
total parenchyma in patients with multiple sclerosis (MS)(n= 41) and age-/sex-matched …

Introduction Pooling of multicenter brain imaging data is a trend in studies on ageing related
brain diseases. This poses challenges to MR-based brain segmentation. The performance …

ABSTRACT BACKGROUND/PURPOSE To assess correlation between brain lesions and
clinical status with 1.5 T and 3T magnetic resonance imaging (MRI). METHODS Brain MRI …